期刊文献+

恶性胸膜间皮瘤32例临床分析 被引量:3

Clinical analysis of 32 patients with malignant pleural mesothelioma
原文传递
导出
摘要 目的 分析恶性胸膜间皮瘤(MPM)的临床特点、诊断及治疗方法.方法 回顾性分析首都医科大学宣武医院2002年1月至2016年10月收治的32例MPM患者的临床资料.结果 MPM患者的主要临床症状为胸痛[18例(56.3%)]、胸闷气促[15例(46.9%)]和咳嗽[7例(21.9%)].CT表现主要为胸膜增厚[29例(90.6%)]和胸腔积液[27例(84.4%)].胸腔积液多为渗出液,以单核细胞增多为主.确诊的方式主要是胸腔镜.早期治疗主要为手术联合化疗,晚期治疗以化疗为主.结论 MPM临床症状不典型,应尽早行胸腔镜胸膜活组织检查术,确诊依靠组织病理学免疫组织化学检查,确诊后尽早给予个体化治疗.
出处 《肿瘤研究与临床》 CAS 2018年第1期60-62,共3页 Cancer Research and Clinic
  • 相关文献

参考文献3

二级参考文献12

  • 1Ceresoli GL, Zucali PA, Gianoncelli L, et al. Second-line treatment for malignant pleural mesothelioma. Cancer Treat Rev, 2010, 36: 24-32.
  • 2van Ruth S, Baas P, Zoetmulder FA. Surgical treatment ol malignant pleural mesothelioma: a review. Chest, 2003, 123:551-561.
  • 3Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet, 2005, 366: 397-408.
  • 4Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetl~xed in combination with eisplatin versus eisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol, 2003, 21: 2636-2644.
  • 5Manegold C, Symanawski J, Gatzemeier U, et al. Second-line (post- study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus eisplatin versus eisplatin alone in malignant pleural mesothetioma. Ann Oncol, 2005, 16: 923-927.
  • 6Rollins KD, Lindley C. Pemetrexed: a multitargeted antifolate. Clin Ther, 2005, 27: 1343-1382.
  • 7Zalcman G, Bergot E, Lechapt E. Pemetrexed re-challenge in pleural ma'lignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting? Lung Cancer, 2011, 72: 1-2.
  • 8Scagliotti GV, Shin DM, Kindler HL, et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol, 2003, 21: 1556-1561.
  • 9van den Bogaert DP, Pouw EM, van Wijhe G, et al. Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma. J Thorac Oncol, 2006, 1 : 25-30.
  • 10Berghmans T, Paesmans M, Lalami Y, et al. Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer, 2002, 38:111-121.

共引文献8

同被引文献13

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部